Schwab, KarimaFrahm, SilkeMagbagbeolu, MandyHorsley, DavidGoatman, ElizabethMelis, ValeriaTheuring, FranzIshaq, AhtshamStorey, John M. D.Harrington, CharlesWischik, ClaudeRiedel, Gernot2024-07-162024-07-162024-05-05Schwab, K, Frahm, S, Magbagbeolu, M, Horsley, D, Goatman, E, Melis, V, Theuring, F, Ishaq, A, Storey, J M D, Harrington, C, Wischik, C & Riedel, G 2024, 'LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy', European Journal of Pharmacology, vol. 970, 176505. https://doi.org/10.1016/j.ejphar.2024.1765050014-2999ORCID: /0000-0001-7063-7136/work/156220008ORCID: /0000-0002-5261-5467/work/156220214ORCID: /0000-0003-2250-3920/work/173415861https://hdl.handle.net/2164/238105013822580engSDG 3 - Good Health and Well-beingAlpha-synucleinAggregation inhibitorParkinson's diseaseMouse modelRM Therapeutics. PharmacologyRC0321 Neuroscience. Biological psychiatry. NeuropsychiatrySupplementary DataDASRMRC0321LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathyJournal article10.1016/j.ejphar.2024.176505970